Medical Journals

Histamine Protects Against Nmda-induced Necrosis in Cultured Cortical Neurons Through H Receptor/Cyclic Amp/Protein Kinase A and H Receptor/Gaba Release Pathways.

Authors:
  • Dai Haibin
  • Zhang Zhongmiao
  • Zhu Yongpin
  • Shen Yao
  • Hu Weiwei
  • Huang Yuwen
  • Luo Jianhong
  • Timmerman Henk
  • Leurs Rob
  • Chen Zhong

From: Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, China 310031.

Journal of neurochemistry

  • Publish Date: Mar 2006
  • ISSN: 0022-3042
  • Volume: 96
  • Issue: 5
  • Pages: 1390-400
  • Medium: Print
  • Language: English
  • Citation (JAMA): Dai Haibin, Zhang Zhongmiao, Zhu Yongpin, et al. Histamine Protects Against Nmda-induced Necrosis in Cultured Cortical Neurons Through H Receptor/Cyclic Amp/Protein Kinase A and H Receptor/Gaba Release Pathways.. J. Neurochem. Mar 2006;96:1390-400

Abstract

Using histamine and the H3 receptor antagonist thioperamide, the roles of histamine receptors in NMDA-induced necrosis were investigated in rat cultured cortical neurons. Within 3 h of intense NMDA insult, most neurons died by necrosis. Histamine reversed the neurotoxicity in a concentration-dependent manner and showed peak protection at a concentration of 10(-7) m. This protection was antagonized by the H2 receptor antagonists cimetidine and zolantidine but not by the H1 receptor antagonists pyrilamine and diphenhydramine. In addition, the selective H2 receptor agonist amthamine mimicked the protection by histamine. This action was prevented by cimetidine but not by pyrilamine. 8-Bromo-cAMP also mimicked the effect of histamine. In contrast, both the adenylyl cyclase inhibitor 9-(tetrahydro-2-furanyl)-9H-purine-6-amine and the cAMP-dependent protein kinase inhibitor N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide reversed the protection by histamine. Thioperamide also attenuated NMDA-induced excitotoxicity, which was reversed by the H3 receptor agonist (R)-alpha-methylhistamine but not by pyrilamine and cimetidine. In addition, the protection by thioperamide was inhibited by the GABA(A) receptor antagonists picrotoxin and bicuculline. Further study demonstrated that the protection by thioperamide was due to increased GABA release in NMDA-stimulated samples. These results indicate that not only the H2 receptor/cAMP/cAMP-dependent protein kinase pathway but also the H3 receptor/GABA release pathway can attenuate NMDA-induced neurotoxicity.

Mesh Headings (Keywords): 8-Bromo Cyclic Adenosine Monophosphate, Animals, Animals, Newborn, Apoptosis, Bicuculline, Cell Survival, Cells, Cultured, Cerebellar Cortex, Cyclic AMP, Cyclic AMP-Dependent Protein Kinases, Dose-Response Relationship, Drug, Drug Interactions, Enzyme Inhibitors, Excitatory Amino Acid Agonists, GABA Antagonists, Histamine, Histamine Agonists, Histamine Antagonists, N-Methylaspartate, Necrosis, Neurons, Picrotoxin, Rats, Rats, Sprague-Dawley, Receptors, Histamine, Time Factors, gamma-Aminobutyric Acid


Check for Full Text / PubMed Unique Identifier (PMID): 16478529


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.